CADL - CIK 0001841387
Candel Therapeutics, Inc. has filed 382 documents with the SEC between 2021 and 2026. The most frequent type is insider trade (148 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| SCHEDULE 13G | - | 2026-05-15 | - |
| Major company event | 8-K | 2026-05-15 | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-14 | 2026-03-31 |
| Major company event | 8-K | 2026-05-14 | 2026-05-14 |
| Annual report to shareholders | ARS | 2026-04-29 | 2025-12-31 |
| Proxy materials | DEFA14A | 2026-04-29 | - |
| Proxy statement | DEF 14A | 2026-04-29 | 2026-06-23 |
| SCHEDULE 13G/A | - | 2026-04-27 | - |
| Insider trade | 4 | 2026-04-02 | 2026-03-31 |
| Insider trade | 4 | 2026-04-02 | 2026-03-31 |
| Insider trade | 4 | 2026-04-02 | 2026-03-31 |
| SCHEDULE 13D/A | - | 2026-03-18 | - |
| Employee stock plan | S-8 | 2026-03-12 | - |
| Annual report | 10-K | 2026-03-12 | 2025-12-31 |
| Major company event | 8-K | 2026-03-12 | 2026-03-12 |
| Insider trade | 4 | 2026-02-26 | 2026-02-23 |
| Major company event | 8-K | 2026-02-23 | 2026-02-19 |
| Prospectus supplement | 424B5 | 2026-02-20 | - |
| Prospectus supplement | 424B5 | 2026-02-19 | - |
| Major company event | 8-K | 2026-02-19 | 2026-02-19 |
| Insider trade | 4 | 2026-01-28 | 2026-01-26 |
| Insider trade | 4 | 2026-01-28 | 2026-01-26 |
| Insider trade | 4 | 2026-01-28 | 2026-01-26 |
| Insider trade | 4 | 2026-01-28 | 2026-01-26 |
| Insider trade | 4 | 2026-01-28 | 2026-01-26 |
| SCHEDULE 13G | - | 2026-01-21 | - |
| Major company event | 8-K | 2025-12-05 | 2025-12-05 |
| Quarterly report | 10-Q | 2025-11-13 | 2025-09-30 |
| Major company event | 8-K | 2025-11-13 | 2025-11-13 |
| Major company event | 8-K | 2025-10-14 | 2025-10-14 |
| EFFECT | - | 2025-08-22 | - |
| Major company event | 8-K | 2025-08-21 | 2025-08-18 |
| Company correspondence | CORRESP | 2025-08-20 | - |
| SEC correspondence | UPLOAD | 2025-08-20 | - |
| Securities registration | S-3 | 2025-08-14 | - |
| Quarterly report | 10-Q | 2025-08-14 | 2025-06-30 |
| Major company event | 8-K | 2025-08-14 | 2025-08-14 |
| Insider trade | 4 | 2025-07-30 | 2025-07-28 |
| Insider trade | 4 | 2025-07-02 | 2025-06-30 |
| Insider sale notice | 144 | 2025-06-30 | - |
| SCHEDULE 13G | - | 2025-06-30 | - |
| Insider trade | 4 | 2025-06-26 | 2025-06-25 |
| Insider trade | 4 | 2025-06-26 | 2025-06-25 |
| Insider trade | 4 | 2025-06-26 | 2025-06-25 |
| Insider trade | 4 | 2025-06-26 | 2025-06-25 |
| Insider trade | 4 | 2025-06-26 | 2025-06-25 |
| Insider trade | 4 | 2025-06-26 | 2025-06-25 |
| Insider trade | 4 | 2025-06-26 | 2025-06-25 |
| Insider trade | 4 | 2025-06-26 | 2025-06-25 |
| Insider trade | 4 | 2025-06-26 | 2025-06-25 |